Views & Analysis Demonstrating the value of RWE A new cross-industry effort hopes to research the benefits of RWE and promote acceptance of alternatives to traditional trials.
R&D Sponsored How to craft responsive clinical trials that are designed fo... Without the right design, right data and right decisions, idealised clinical trial plans cannot be translated into blueprints for robust studies.
Views & Analysis Searching for new hope in Alzheimer’s For the best part of two decades, it seemed as if pharma hit a brick wall as it tried to find new treatments for Alzheimer’s.
Views & Analysis Q&A: Albireo’s Ron Cooper on bile acid modulation While bile acids might not be as trendy as gene editing, modulating them has potential for first-in-class therapies for liver diseases.
Views & Analysis Q&A: Sangamo’s Duncan McKay on genomic medicines We talk to Duncan McKay, senior vice president and general manager, Europe of Sangamo Therapeutics, about the future of genomic medicines and how healthcare systems may need to adapt to
Oncology On the benefits of earlier oncological intervention, with Jo... As ESMO 2026 came to a close, pharmaphorum web editor Nicole Raleigh spoke with Johnson & Johnson Innovative Medicine’s Carolyn Sousa and Henar Hevia
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
